47 POSTER A phase II study of Sorafenib (BAY 43-9006) in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal cancer (NPC): final results Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Elser, C
  • Siu, L
  • Winquist, E
  • Agulnik, M
  • Pond, Gregory
  • Chin, S
  • Francis, P
  • Cheiken, R
  • Petrenciuc, O
  • Chen, E

publication date

  • November 2006